Feed RANI
RA
Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
$0.80 +1.93% (+$0.02)
1M +19.11%
Market Cap $52.1M
P/E Ratio -
Div. Yield -
ROE 245.46%
Bulios Fair Price
$1.02
28.1% upside
Preț actual
$0.8
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile RANI sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
46 /100
Fair P/B 1.83x
P/S 30.51x
PEG N/A
Growth
7 /100
Declining Book val. growth 3.61%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak FCF margin 1,001.99%
Op. margin 2,027.81%
Gross margin 90.57%
Quality
0 /100
Poor Asset turnover 0.03x
ROA 56.75%
ROIC 87.72%
Debt
69 /100
Low Current ratio 3.40x
Int. coverage -18.97x
Debt/Equity 0.14x
Stability
65 /100
Moderate EPS volatility 30.69%
Profitable years 0
Beta 0.70x
Întreabă StockBot despre RANI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Talat Imran
Employees
71
Headquarters
San Jose
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report